An update on the diagnosis and treatment of pediatric pulmonary hypertension |
| |
| Authors: | F. Rana Olguntürk |
| |
| Affiliation: | 1. Professor of Pediatrics and Pediatric Cardiology, PhD in medical physiology, Former Head of Pediatrics and Pediatric Cardiology in Gazi University Faculty of Medicine. Founder of Pediatric Cardiology and PAH center in Gazi University. Former President of Turkish Association of Pediatric Cardiology and Surgery, Gazi University , Ankara, Turkiye ranaolgunturk@gmail.com |
| |
| Abstract: | ABSTRACT Introduction Pulmonary hypertension (PH) is a heterogeneous disease that mainly affects the pulmonary arterioles, leading to significant morbidity and mortality. Pulmonary hypertension in children from birth to adolescence presents important differences from that of adults. The majority of pediatric pulmonary arterial hypertension (PAH) cases are idiopathic or associated with congenital heart disease. However, the management of pediatric PAH mainly depends on the results of evidence-based adult studies and the clinical experiences of pediatric experts. |
| |
| Keywords: | Children new treatment targets pediatrics pharmacotherapies pulmonary arterial hypertension guidelines for therapy |
|
|
